{
    "nctId": "NCT05769751",
    "briefTitle": "A Study to Describe the Real-world Treatment Patterns and Associated Outcomes in Patients of China With HER2-positive Unresectable or Metastatic Breast Cancer",
    "officialTitle": "A Multicenter, Non-interventional Retrospective Study to Describe the Real-world Treatment Patterns and Associated Outcomes in Patients of China With HER2-positive Unresectable or Metastatic Breast Cancer",
    "overallStatus": "COMPLETED",
    "conditions": "HER2-positive Breast Cancer",
    "studyType": "OBSERVATIONAL",
    "phase": "N/A",
    "allocation": "N/A",
    "primaryPurpose": "N/A",
    "enrollmentCount": 865,
    "primaryOutcomeMeasure": "Percentage of Participants Receiving Each Regimen in Each Treatment Line",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Male or female patients \u2265 18 years of age at the time of diagnosis of unresectable or metastatic breast cancer\n* Participants with first diagnosis of unresectable or metastatic breast cancer, or first recurrence of HER2-positive breast cancer since January 1, 2020. Participants were eligible if they were HER2-positive in the early operable stage and HER2-negative in the advanced stage. HER2 positive was defined with the reference to the Chinese guidelines for HER2 positive breast cancer at the time of testing\n* Participants have received at least one systemic therapy for advanced breast cancer\n\nExclusion Criteria:\n\n* Participants with concomitant cancer at the time of diagnosis of HER2-positive unresectable or metastatic breast cancer, except for the non-metastatic non-melanoma skin cancers, or in situ or benign neoplasms; a cancer is considered concomitant if it occurs within 5 years of HER2-positive breast cancer diagnosis.\n* Participants who are/were currently/previously enrolled in a clinical trial and have not been unblinded during the data collection interval of the study\n* Participants with critical missing data from their medical records or other patients deemed by the investigator to be ineligible for inclusion",
    "sex": "ALL",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}